Sumitomo Pharma Achieves 300.5% Return, Leading Stock Performance in Pharmaceuticals
Over the past year, notable stock performances have emerged across various sectors, highlighting diverse investment opportunities. Sumitomo Pharma Co., Ltd. led with an impressive 300.5% return in the Pharmaceuticals & Biotechnology sector, underscoring its strong industry position. Kirin Holdings Co., Ltd. followed with a solid 32.82% return in Beverages, reflecting robust consumer demand. In the micro-cap space, Axis Co., Ltd. achieved an 8.92% return in Software Products, while Tay Two Co., Ltd. recorded a 2.13% return in Media & Entertainment, indicating growth potential despite a competitive landscape.
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
